Skip navigation

Search results for the

Showing 61 to 75 of 417 results

Call-out for working group members following consultation closure

The HCPC consultation on the Standards of conduct, performance and ethics, and accompanying guidance on social media closed on 16 June 2023.

HCPC response to DHSC healthcare regulation consultation

As we move forward with the wider programme of regulatory reform, we welcome this consultation to consider how the powers to introduce and remove professions from regulation might be used in the future.

Now open: HCPC student competition 2024! #HCPCstudentcomp

For the third year running, the HCPC has opened its student competition. 

August bank holiday 2023 service availability

The HCPC offices will be closed on Monday 28 August for the summer bank holiday weekend

HCPC publishes Fitness to practise annual report 2019

The report highlights key statistics and insights and explains how we protect the public and ensure our registrants meet our standards

HCPC updates standards of proficiency

The HCPC has updated its standards of proficiency for the first time since 2015. The crucial changes have been made following an extensive period of engagement with a wide range of stakeholders, to seek views and develop standards in line with current professional practice.

Dietitian renewals - window closing soon

The deadline for dietitians to complete their registration renewal is fast approaching

PSA review highlights significant progress made by the HCPC

The Professional Standards Authority (PSA) has today published its annual performance review of the HCPC. The HCPC has met 16 of the 18 Standards of Good Regulation, regaining two fitness to practise (FTP) standards and one standard linked to registration.

Launch date announced for specialist social work regulator

Nadhim Zahawi has announced Monday 2 December 2019 as the date when Social Work England will take over from the HCPC as the new social work regulator

Reclassification of Gabapentin and Pregabalin

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

Top